News | September 18, 2025
Bayer inaugurates new phytomedicines lab facility
The lab will facilitate the development of herbal and natural-based solutions
The lab will facilitate the development of herbal and natural-based solutions
This marks the first of four new U.S. manufacturing sites that Lilly plans to announce this year
Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks
Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US
IND application for EB-003 expected in early 2026
The inspection was carried out between May 26, 2025 and May 31, 2025
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Subscribe To Our Newsletter & Stay Updated
